Citron: This Weed Stock is 'All Hype'

Citron accused cannabis company Cronos Group of misleading investors

Managing Editor
Aug 30, 2018 at 2:40 PM
facebook X logo linkedin


Stocks are sliding today, as the deadline for a U.S.-Canada trade deal looms. Looking at individual stocks, shares of weed stock Cronos Group Inc (NASDAQ:CRON), biotech Eagle Pharmaceuticals Inc (NASDAQ:EGRX), and oil services stock RPC, Inc. (NYSE:RES) are all lower. Here's a closer look at what's moving shares of CRON, EGRX, and RES.

Options Bears Pile On CRON After Citron Report

Cronos stock is down 28.6% to trade at $9.09, after notorious short seller Citron Research tweeted that the company is "everything that is contaminated about the Cannabis space. ALL HYPE with possible securities fraud."

While setting a price target of $3.50 -- representing expected downside of 73% drop from yesterday's close of $12.74 -- Citron's report claims Cronos is "deceiving the investing public by purposely not disclosing the size of its distribution agreements with [Canadian] provinces - unlike every other major cannabis player." Further, Citron's sources say it's because the supply agreements are "so small they could never justify the premium investors are paying for the stock."

Like most other weed stocks, CRON broke out in a big way earlier this month, with help from reports of Diageo's (DEO) interest in cannabis suppliers. This culminated in a record high of $12.89 on Monday, Aug. 27 -- representing a 128% surge from the equity's close of $5.65 on Aug. 14. Even with today's plunge, Cronos shares are still up more than 55% month-to-date.

In addition, it seems a near-term pullback may have been in the cards for Cronos stock. The stock sported a 14-day Relative Strength Index (RSI) of 81 at last night's close -- well into overbought territory.

In response to the pullback, options bears have come out of the woodwork. Over 75,000 CRON puts have changed hands today, 25 times the average intraday volume and already more than three times yesterday's annual high of just over 18,000 puts. Leading the charge is the weekly 9/7 11.50-strike put, where new positions are being opened. Buyers of the puts expect CRON to extend its retreat south of $11.50 through the end of next week.

Low Enrollment Numbers Sink EGRX

Eagle Pharmaceuticals stock is down 13.3% to trade at $70.76, one of the worst stocks on the Nasdaq today, after reporting low enrollment numbers for a study of Ryanodex, the company's heat stroke drug. EGRX is on track for its worst day and month since July 2017, down more than 10% in August. In the shorter term, the shares are in danger of breaching their 100-day moving average for the first time since May. 

Although Eagle stock is currently on the short-sale restricted (SSR) list, short sellers are likely cheering today's drop. Short interest increased by 8% in the most recent reporting period to 2.59 million shares, the most since early May. This represents a whopping 26% of EGRX's total available float.

Analyst Sees Subpar Quarterly Results Ahead For RPC

RES stock is down 7.4% to trade at $13.32 after SunTrust Robinson downgraded the oil services name to "hold" from "buy," while slashing its price target to $16 from $25. The analyst in coverage forecast weaker earnings numbers over the next few quarters. RES is dangerously close to its July 25 two-year low of $13. The shares have now shed 47% in 2018, and the $15.50-$16 level has provided stiff overhead resistance since June.

Again, though, several short sellers are likely celebrating today. Short interest on RES surged nearly 60% in the past two reporting periods, and now accounts for close to 40% of the stock's total available float.

 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI